Accolade
Buying intent
50 tracked signals | Top 15 topics are below | Operations and Engineering are carrying most of it.
Attention by team
LinkedIn activity, by teamWhere Accolade's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
8d ago
9d ago
11d ago
21d ago
9d ago
12d ago
9d ago
21d ago
24d ago
5d ago
31d ago
12d ago
15d ago
23d ago
31d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at Accolade
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
See everyone, not just the first 10
15 people across every department at Accolade, plus a LinkedIn profile link for each.
Primary products / business lines
LinkedIn company profileAccolade is now a part of Transcarent. We are the One Place for Health and Care, bringing medical, pharmacy, and point solutions together with the WayFinding™ experience, the first and only generative AI-powered health and care platform for health consumers. Our WayFinding experience, paired with transparent and consumer-driven pharmacy care, 2nd.MD expert medical opinions, and virtual primary car
Top accounts researching Accolade
names withheld on the public pageThese are companies whose own people brought up Accolade unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
129,094 companies · 649,540 people are researching Artificial Intelligence
Accolade's own team shows 9 signals on this topic. No one outside Accolade has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Professional Development30,876 cos · 191,941 people
- Hiring66,174 cos · 318,882 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)Engineering — 3 people; HR / Talent — 2 people; Operations — 1 person; IT — 1 person; Marketing — 1 person; Security — 1 person
What's been said
public posts by Accolade's teamNo public post naming Accolade has surfaced in the past year, so this is what Accolade's own team is posting about publicly — their topics, in their words.
Happy to run with my son for his first race to support #hopetravels5k #helphopelive
May 2026I’m proud to be part of a movement that’s transforming how people experience health and care. When Transcarent launched the WayFinding™ experience in 2024, we redefined what was possible with AI-powered healthcare navigation, and we haven’t stopped innovating since. By listening closely to our Members and clients, and applying cutting-edge technologies like agentic AI, we’re continuing to push healthcare forward. This is what people really need: an experience that anticipates what’s next and takes action on their behalf to help them move forward with greater confidence and less friction. Just Ask Transcarent. We’ll take it from here.
May 2026We’re building the future of health and care! By expanding the Transcarent WayFinding™ experience to include a partnership with SmithRx, we’re helping Members get the right prescriptions at the right price—without the usual confusion. I’m proud to be part of a team making pharmacy simpler, clearer, and more affordable for everyone. This is what changing the status quo in pharmacy looks like!
May 2026⚡ Who's heading to SWBA's 51st Annual Conference – THUNDERSTRUCK: Electrifying Employee Benefits?! I'll be at the Omni Oklahoma City Hotel May 6–8 and would love to connect while I'm there. If you're attending, let me know in the comments or shoot me a message — let's set up some time to meet up, swap ideas, and grab a coffee or two ☕ Can't wait to see what this year has in store! #SWBA #EmployeeBenefits #Thunderstruck #Conference #OKC
Apr 2026"We have one job - get TWO signatures on ONE piece of paper." - so said an early sales leader of mine (shout out James Kelly, MBA ). It sounds simple, but it's actually profound. Because it was shared in the context of the internal sale - and over time, I've realized just how much that holds up. The external sale is only half the battle. If you don't have internal alignment across the organization - Product, Finance, Clinical, Delivery - you don't have a deal. All you have is hope... The internal sale is the difference between deals that close and deals that actually stick, expand, and compound. The difference between indifferent customers and raving fans. Some of the most important deals I've been a part of required just as much internal alignment as external. When done well, you expand what your company is capable of. Frontline sellers have the unique privilege of shaping: * New pricing models that unlock different buyer segments * New delivery approaches that make previously "hard" deals winnable * Product feedback loops that sharpen the roadmap * Confidence that "we can do this again" with repeatability What separates a strong internal sale from a painful one? 1. Build relationships before you need them. If the first time you're engaging internal stakeholders is to "get approval," you're already behind (and likely slowing down your deal). 2. Translate the deal into their language and tell more than just the revenue story. Finance: margin, risk, repeatability Product: roadmap integrity, scalability Delivery: feasibility, operational load 3. Show the ROI of expanded capability. The best internal sales create leverage beyond a single deal - they make the business better, not just bigger. 4. De-risk early and often. Surface objections, tighten the story, and remove ambiguity before others have to. The best sellers I've seen aren't just great externally. They're exceptional at orchestrating internal alignment - turning complexity into clarity and hesitation into conviction. Because at the end of the day, we still have one job... Get two signatures. On one piece of paper. Funny the one-liners that stick with you throughout your career. Curious - what pearls of wisdom have stayed with you?
Apr 2026“People don’t Google anymore, they use AI.” I don’t think that’s true. AI is great for exploring. You ask questions, get ideas, narrow things down. But when you actually want to buy something, people still go to Google. Because the way people search changes when money is involved. It goes from: → “what’s the best CRM?” to: → “HubSpot vs Salesforce pricing UK” From: → “good headphones?” to: → “buy Sony WH-1000XM5 near me” That shift matters. One is curiosity. The other is intent. And intent is what drives revenue. AI isn’t replacing search. If anything, it’s sending more informed people into it. People who already know what they want. People who are closer to making a decision. So no, search isn’t going anywhere. If anything, it’s where the most valuable users still are.
Apr 2026Old habits are hard to break—even after the market has stopped rewarding them. For years, revenue was defined by one thing: new logos. Land the deal. Hit the number. Move on. And for a while, that worked. Capital was cheap, expectations were different, and growth—even if it was fragile—was enough. But the standard has changed. Today, boards aren’t asking how fast you’re growing. They’re asking whether that growth will hold. Whether it will expand. Whether it’s actually building enterprise value—or just pulling demand forward. That’s the difference between growth and durable growth. New logo growth still matters. It’s just no longer sufficient on its own. What’s interesting is that while the market has clearly shifted, many operating models haven’t. Sales teams are still optimized for bookings. Post-sale teams are still left managing the consequences. And leaders are still surprised when “strong growth” turns into churn and contraction—or worse, undermines their ability to win new logos in the next buying cycle. Because durable growth doesn’t get solved at renewal. It’s built much earlier—with a clear, disciplined ICP and with tight alignment between acquisition and post-sale teams. What gets sold has to be what can be delivered, adopted, and grown. Otherwise, you’re just pushing risk forward in the system—at the expense of your customers. The companies pulling ahead are operating differently. They’re treating revenue as a single system—with shared accountability for not just how revenue is created, but how it performs over time. Because in this market, growth that doesn’t hold isn’t growth. It’s value-destructive.
Apr 2026